Latest filing published 29 May 2007 for Marina Biotech, Inc., €5,779.
Insider track record
No signal scores available.
David E. Wormuth: trading record in brief
All filings by David E. Wormuth on record concern Marina Biotech, Inc. We count 109 filings; the first trade dates from 23 January 2006 and the latest from 25 May 2007.
No open-market purchase appears, only 103 sales worth €359k. Besides market trades, the filings include 2 share grants and 4 option exercises.
On 29 May 2007 came the latest disclosure, a share grant for €5,779 in Marina Biotech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David E. Wormuth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 661 shares@ US$11.76Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-033446:0
- 19,500 shares0Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-008756:0
- 2,000 shares@ US$13.55Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-033427:0
- 200 shares@ US$13.56Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-033427:1
- 200 shares@ US$13.60Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-033427:2
- 100 shares@ US$13.62Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-033427:3
- 4,167 shares@ US$8.21Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:0
- 100 shares@ US$16.58Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:1
- 100 shares@ US$16.59Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:2
- 200 shares@ US$16.61Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:3
- 100 shares@ US$16.62Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:4
- 100 shares@ US$16.64Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:5
- 100 shares@ US$16.65Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:6
- 300 shares@ US$16.68Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:7
- 200 shares@ US$16.70Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:8
- 100 shares@ US$16.72Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:9
- 100 shares@ US$16.73Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:10
- 200 shares@ US$16.76Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:11
- 100 shares@ US$16.77Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:12
- 100 shares@ US$16.79Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:13
- 100 shares@ US$16.80Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:14
- 300 shares@ US$16.83Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:15
- 200 shares@ US$16.84Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:16
- 167 shares@ US$16.85Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:17
- 400 shares@ US$16.86Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-019654:18
25 of 109 declarations